OTCMKTS:ISCNF Isracann Biosciences (ISCNF) Stock Price, News & Analysis → The new financial threat that could wipe out millions… (From InvestorPlace) (Ad) Free ISCNF Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$0.0001▼$0.011052-Week Range N/AVolumeN/AAverage Volume110,335 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest Get Isracann Biosciences alerts: Email Address Ad InvestorPlaceThe new financial threat that could wipe out millions…During the Internet boom, companies like Pets.com were supposed to be promising investments riding the wave of a new tech boom. But then they were gone within a blink of an eye. One of the most successful investors in history just stepped forward to say the same thing is about to happen to AI stocks.Pay close attention to this important video About Isracann Biosciences Stock (OTCMKTS:ISCNF)Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.Read More Ad InvestorPlaceThe new financial threat that could wipe out millions…During the Internet boom, companies like Pets.com were supposed to be promising investments riding the wave of a new tech boom. But then they were gone within a blink of an eye. One of the most successful investors in history just stepped forward to say the same thing is about to happen to AI stocks.Pay close attention to this important video ISCNF Stock News HeadlinesApril 6, 2023 | finance.yahoo.comIIROC Trading Halt - IPOTApril 6, 2023 | finance.yahoo.comIsracann Biosciences Inc. (ISCNF)May 8, 2024 | Behind the Markets (Ad)The Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.October 25, 2022 | seekingalpha.comISCNF Isracann Biosciences Inc.October 13, 2022 | finance.yahoo.comIsracann Biosciences Provides Bi-Weekly Default Status ReportSeptember 28, 2022 | finance.yahoo.comIsracann Bioscience Facilitated Genetics Arrive in IsraelSeptember 14, 2022 | benzinga.comIsracann Bioscience Facilitates Cannabis Genetics Shipment To IsraelSeptember 1, 2022 | msn.comIsracann's Praesidio Expands Its Natural Health Products Distribution Network: Inks Deal With Pure Integrative PharmacyMay 8, 2024 | Behind the Markets (Ad)The Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.September 1, 2022 | financialpost.comPraesidio signs distribution agreement with Pure Integrative PharmacyAugust 25, 2022 | proactiveinvestors.comIsracann Biosciences adds Super Bowl MVP Mark Rypien to company advisory boardAugust 23, 2022 | finance.yahoo.comIsracann Adds Super Bowl MVP and Mental Health Advocate Mark Rypien to Advisory BoardAugust 3, 2022 | msn.comCannabis Company Isracann Biosciences Raises $234K In The First Tranche Of Private PlacementAugust 3, 2022 | finance.yahoo.comIsracann Biosciences Announces Closing of First Tranche of $0.05 Unit Private PlacementMay 21, 2022 | msn.comIsracann Biosciences' Subsidiary Praesidio Health Submits NPNs To Health CanadaMay 19, 2022 | finance.yahoo.comIsracann Biosciences Subsidiary Praesidio Health Submits NPNs to Health CanadaApril 15, 2022 | financialpost.comIsracann Biosciences Renews Leadership to Meet Changing DemandsApril 14, 2022 | seekingalpha.comIsracann Biosciences acquires Praesidio Health and appoints products officersApril 14, 2022 | msn.comIsracann Biosciences Acquires Praesidio Health And Appoints Natural Health Products OfficersApril 13, 2022 | finance.yahoo.comIsracann Biosciences Acquires Natural Health Medicine Developer and Appoints Natural Health Products OfficersMarch 28, 2022 | msn.comIsracann Biosciences Signs Definitive Agreement To Acquire Praesidio Health For $3.18MMarch 28, 2022 | seekingalpha.comIsracann Biosciences to acquire Canadian natural health medicine developerMarch 28, 2022 | finance.yahoo.comIsracann Biosciences Signs Definitive Agreement to Acquire Natural Health Medicine DeveloperFebruary 24, 2022 | finance.yahoo.comUPDATE - Isracann Signs LOI to Acquire Natural Health Medicine DeveloperFebruary 23, 2022 | seekingalpha.comIsracann to acquire natural health medicine developerFebruary 23, 2022 | msn.comIsracann To Acquire Natural Health Medicine Developer Praesidio Health For $3.14MFebruary 23, 2022 | financialpost.comIsracann Signs LOI to Acquire Natural Health Medicine DeveloperSee More Headlines Receive ISCNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Isracann Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:ISCNF CUSIPN/A CIKN/A Webwww.isracann.com Phone604-394-2551FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesAjay Singh KailaInterim Chief Executive OfficerKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors ISCNF Stock Analysis - Frequently Asked Questions How do I buy shares of Isracann Biosciences? Shares of ISCNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ISCNF) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Isracann Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
